切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (04) : 468 -472. doi: 10.3877/cma.j.issn.1673-5250.2013.04.009

所属专题: 文献

论著

巨大儿的发生及其影响因素
陈蔚1, 武明辉1,*,*(), 张娣1, 侯东敏1, 王军华1, 蒋京伟1, 贾朝霞1   
  1. 1. 100026 北京,首都医科大学附属北京妇产医院 北京妇幼保健院
  • 收稿日期:2013-01-20 修回日期:2013-06-18 出版日期:2013-08-01
  • 通信作者: 武明辉

Occurrence and Influencing Factors of Macrosomia

Wei CHEN1, Ming-hui WU1(), Di ZHANG1, Dong-min HOU1, Jun-hua WANG1, Jing-wei JIANG1, Zhao-xia JIA1   

  1. 1. Capital Medical University Affixed Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Children Health Hospital, Beijing 100026, China
  • Received:2013-01-20 Revised:2013-06-18 Published:2013-08-01
  • Corresponding author: Ming-hui WU
  • About author:
    (Corresponding author: WU Ming-hui, Email: )
引用本文:

陈蔚, 武明辉, 张娣, 侯东敏, 王军华, 蒋京伟, 贾朝霞. 巨大儿的发生及其影响因素[J/OL]. 中华妇幼临床医学杂志(电子版), 2013, 09(04): 468-472.

Wei CHEN, Ming-hui WU, Di ZHANG, Dong-min HOU, Jun-hua WANG, Jing-wei JIANG, Zhao-xia JIA. Occurrence and Influencing Factors of Macrosomia[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(04): 468-472.

目的

探讨产妇分娩巨大儿的危险因素。

方法

自2010年1月至12月在本院产科分娩的产妇中,选取病历资料完整的7805例产妇(单胎妊娠)为研究对象。按照产妇分娩新生儿的出生体重,将其入组巨大儿组(n=593,出生体重≥4000 g)和正常体重儿组(n=7212,4000 g>出生体重≥2500 g)。采取回顾性分析法对两组产妇的相关指标,如体重指数(BMI),葡萄糖耐量试验(OGTT)结果及产妇的一般情况、孕期体重、血糖、分娩情况等进行单因素分析。对单因素分析中有统计学意义的指标,进行非条件多因素logistic回归分析(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准,得到该委员会批准,分组征得受试对象本人的知情同意,并与之签署临床研究知情同意书)。

结果

①两组产妇的分娩年龄、产前检查开始孕龄、产次、新生儿窒息率等比较,差异无统计学意义(P>0.05)。②巨大儿组产妇孕次、孕前体重与BMI,产前体重与BMI、空腹血糖值及OGTT 1 h,2 h血糖值,分娩孕龄、方式与新生儿性别、出生体重、窒息率等与正常体重儿组产妇比较,差异有统计学意义(P<0.05)。③分娩孕龄≥40孕周、产前肥胖、孕次为6次、分娩方式为剖宫产、空腹血糖≥5.1 mmol/L、分娩男胎及OGTT 2 h血糖≥8.5 mmol/L是巨大儿发生的高危因素。

结论

控制空腹及餐后2 h血糖,控制孕期体重增加,降低产前BMI,适时终止妊娠等,可降低巨大儿的发生。

Objective

To investigate the risk factors of gestational women who delivered macrosomia.

Methods

Clinical data of 7805 pregnant women(singleton pregnancy)who had antenatal care and delivered in Capital Medical University Affixed Beijing Obstetrics and Gynecology Hospital from January to December 2010 were retrospectively analyzed. According to birthweight of neonats, they were divided into macrosomia group (n=593, birthweight≥4000 g) and normal neonate weight group(n=7212, 4000 g>birthweight≥2500 g). All the indicators relevant to macrosomia were analyzed, such as body mass index(BMI), oral glucose tolerance test(OGTT), common situation, gestational weight, blood glucose and delivery situation. They were firstly analyzed by univariate analysis method. Then the meaningful indicators were analyzed by non-conditional multivariate logistic regression method.The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Capital Medical University Affixed Beijing Obstetrics and Gynecology Hospital. Informed consent was obtained from the parents of each participating neonate.

Results

①There had significance difference between two groups among ages, parities, gestational age at time to begin antenatal examination and asphyxia rate of neonates(P>0.05). ②There had significance difference between two groups among gravidities, pre-pregnancy weight, pre-pregnancy BMI, prenatal weight, prenatal BMI, gestational weight gain, fasting plasma glucose, levels of OGTT 1 h, 2 h, gestational age, modes of delivery, gestational age at delivery, and birth weight, sex of neonates(P<0.05). ③Analyzed by non-conditional multivariate logistic regression showed those high risk factors for macrosomia were gestational age≥40 weeks, BMI≥28 kg/cm2 at delivery, the number of pregnancies reaching 6, cesarean section, fasting plasma glucose≥5.1 mmol/L, male fetus and blood glucose levels of OGTT 2 h≥8.5 mmol/L.

Conclusions

To control levels of fasting plasma glucose and levels of postprandial blood glucose, keep the gestational weight in appropriate ranges, decrease the prenatal BMI and terminate pregnancy timely can reduce incidence of macrosomia.

表1 两组产妇及新生儿的一般临床资料的单因素分析结果比较[n(%)]
Table 1 Comparison of general clinical data between two groups of pregnant women and neonatals[n(%)]
组别 n 分娩年龄(岁,±s) 孕次(次) 产次(次) ?
1 2~3 4~5 6 1 ≥2
巨大儿组 593 30.1±3.4 254(42.83) 286(48.23) 44(7.42) 9(1.52) 544(91.7) 49(8.3)
正常体重儿组 7212 30.4±3.7 3613(50.10) 3057(42.39) 480(6.66) 62(0.86) 6642(92.1) 570(7.9)
χ2/t ? 1.74 13.29 0.08
P ? 0.082 0.004 0.96
组别 产前检查开始孕龄(孕周,±s) 孕前体重(kg,±s) 孕前BMI(kg/m2)
低体重 正常(理想)体重 超重 肥胖
巨大儿组 17.8±4.5 59.5±8.3 49 (8.2) 413(69.7) 108(18.2) 23(3.9)
正常体重儿组 17.5±4.3 55.1±8.0 1349(18.7) 4976(69.0) 728(10.1) 159(2.2)
χ2/t -1.20 -12.61 73.47
P 0.231 0.000 0.000
组别 产前体重(kg,±s) 产前BMI(kg/m2) 空腹血糖(mmol/L)
低体重 正常(理想)体重 超重 肥胖 <5.1 ≥5.1
巨大儿组 78.6±9.3 0(0.00) 19 (3.2) 202(34.1) 371(62.6) 490(82.6) 103(17.4)
正常体重儿组 71.9±9.1 2(0.02) 1009(14.0) 3627(50.3) 2574(35.7) 6615(91.7) 593 (8.3)
χ2/t -17.33 187.04 55.47
P 0.000 0.000 0.000
组别 OGTT 1 h血糖(mmol/L) OGTT 2 h血糖(mmol/L) 分娩方式
<10.0 ≥10.0 <8.5 ≥8.5 产钳 剖宫产 自然产
巨大儿组 519(87.5) 74(12.5) 538(90.7) 55(9.3) 10(1.7) 363(61.2) 220(37.1)
正常体重儿组 6541(90.7) 671 (9.3) 6750(93.6) 462(6.4) 159(2.2) 3253(45.1) 3801(52.7)
χ2/t 6.52 7.26 57.51
P 0.008 0.006 0.000
组别 胎膜早破 分娩孕龄(孕周) 新生儿性别
37~38 38~39 39~40 ≥40
巨大儿组 105(17.7) 488(82.3) 12(2.0) 91(15.3) 162(27.3) 328(55.3) 390(65.8) 203(34.2)
正常体重儿组 1623(22.5) 5589(77.5) 618(8.6) 2049(28.4) 2188(30.3) 2356(32.7) 3721(51.6) 3491(48.4)
χ2/t 7.20 146.34 44.15
P 0.007 0.000 0.000
组别 新生儿体重(g,±s) 新生儿窒息率
巨大儿组 4220.1±210.0 5(1.5)
正常体重儿组 3350.0±324.5 52(0.7)
χ2/t 92.24 3.50
P 0.000 0.061
表2 巨大儿发生的相关因素非条件多因素logistic回归分析结果
Table 2 Analysis of the relative factors in macrosomia with non-conditional multivariate logistic regression
1
Yue J, ed. Obstetrics and gynecology.7th ed[M].Beijing:People's Medical Publishing House,2008,123.
2
Eriksson M, Wedel H, Wallander MA, et al. The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age[J]. Prostate, 2007,67:1247-1254.
3
Harder T, Plagemann A, Harder A. Birth weight and subsequent risk of childhood primary brain tumors:A Meta-analysis[J]. Am J Epidemiol, 2008,168:366-373.
4
Hjalgrim LL, Westergaard T, Rostgaard K, et al. Birth weight as a risk factor for childhood leukemia: A Meta-analysis of 18 epidemiologic studies[J]. Am J Epidemiol, 2003,158:724-735.
5
Remes ST, Patel SP, Hartikainen AL, et al. High birth weight, asthma and atopy at the age of 16[J]. Pediatr Allergy Immunol, 2008,19:541-543.
6
China Obesity Task Guide Working Group. The Chinese adult body mass index classification recommendations[J].Chin J Prev Med,2001,35(5):394-350.
7
Lu YY, Zhang J, Lu XR, et al. Secular trends of macrosomia in southeast China, 1994-2005[J]. BMC Public Health, 2011,11:818-826.
8
Gyurkovits Z, Kálló K, Bakki J, et al. Neonatal outcome of macrosomic infants: An analysis of a two-year period[J]. Eur J Obstet Gynecol Reprod Biol, 2011,159:289-292.
9
Grissa O, Atègbo JM, Yessoufou A, et al. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia[J]. Translat Res, 2007,150: 164-171.
10
Donma MM. Macrosomia, top of the iceberg :The charm of underlying factors[J]. Pediatr Int,2011,53:78-84.
11
Hermann GM, Dallas LM, Haskell SE, et al. Neonatal macrosomia is an independent risk factor for adult metabolic syndrome[J]. Neonatology, 2010, 98:238-244.
12
Sun WJ, Zhu SL, Yang HX, et al.Influencing factors on insulin administration in women with gestational diabetes mellitus[J/CD].Chin J Obstet Gylycol Pediatr, 2009,5(4):151-154.
13
Bhattacharya S, Campbell DM, Listion WA. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies[J]. BMC public Health. 2007,7:168.
14
Kabali C, Werler MM. Pre-pregnant body mass index, weight gain and the risk of delivering large babies among non-diabetic mothers[J]. Int J Gynaecol Obstet,2007,97:100-104.
15
IADPSG Consensus Panel.International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J]. Diabetes Care, 2010,33: 676-682.
16
Langer O. Fetal macrosomia:Etiologic factor[J]. Clin Obstet Gynecol,2000,43:283-297.
17
Sun PP, Li HP, Zhao F.Analysis of risk factors for macrosomia in pregnant women with abnormal glucose metabolism[J]. J Pract Obstet Gynecol,2012,28:64-67.
18
Parretti E, Mecacci F, Papini M, et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: Correlation with sonographic parameters of fetal growth[J]. Diabetes Care, 2001,24:1319-1323.
19
Jin R, Cheng HD.Correlation of fetal macrosomia to glucose metabolism in pregnant woman[J]. J Pract Obstet Gynecol,2006, 22:239-240.
20
Yu DM, Zhai FY, Zhao LY,et al.Incidence of fetal macrosomia and influencing factors in China in 2006[J].Chin J Child Healt Care,2008,16(1):11-13.
21
Ezegwui HU, Ikeako LC, Egbuji C. Fetal macrosomia :Obstetric outcome of 311 cases in UNTH, Enugu, Nigeria[J]. Niger J Clin Pract, 2011,14:322-326.
22
Fu Q, Fan JX.Related factor analysis of 474 cases with macrosomia[J].Chin J Woman Child Healt Res,2011,22(5):581-583.
23
Cheng YW, Nicholson JM, Nakagawa S, et al. Perenatal outcomes in low-risk term pregnancies:Do they differ by week of gestation[J].Am J Obstet Gynecol,2008,199(4):370.E1-E7.
24
Ju H, Chadha Y, Donovan T, et al. Fetal macrosomia and pregnancy outcomes[J]. Aust NZ J Obstet Gynaecol,2009,49:504-509.
25
Di Renzo GC, Rosati A, Sart RD, et al. Does fetal sex affect pregnancy outcome[J]? Gend Med,2007,4:19-30.
[1] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[2] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[3] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[4] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[5] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[6] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[7] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[8] 房桂彬, 肖进, 傅光涛, 郑秋坚. 老年髋部骨折患者术后1年行走能力的影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 273-280.
[9] 单良, 刘怡, 于涛, 徐丽. 老年股骨颈骨折术后患者心理弹性现状及影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 294-300.
[10] 王如海, 王绅, 张敏, 李春, 韩超, 于强, 胡海成, 李习珍. 重型创伤性脑损伤患者去骨瓣减压术后短期死亡风险的影响因素分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 285-291.
[11] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[12] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[13] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[14] 黄晓云, 姚雅极. 院前急救医师职业寿命影响因素与对策思考[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 281-285.
[15] 曹慧, 刘华, 赵婷奕, 唐茂庆, 韩骐, 于永华. 非酮症高血糖性偏身舞蹈症一例报道及文献回顾[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 501-505.
阅读次数
全文


摘要